TRUST130, 213, United AMR Hospitals Susceptibility S. 245 States surveillance funded data for pneumoniae (~434 respiratory H. influenzae publications healthcare tract infections; M. catarrhalis institutions; resistance centralised trends over time and geographic region AWARE United AMR Organism Hospitals Susceptibility S. surveillance States resistance funded testing of pneumoniae program246 (9 US respiratory or H. influenzae publications census bloodstream M. catarrhalis regions; 71 isolates medical against centres) ceftaroline and comparators ARMOR247 United Surveillance Infection/ Healthcare Susceptibility S. aureus States study funded organism institutions profile of (34 (Bausch & isolates from publications institutions) Lomb, ocular staphylococci, Eurofins infections S. Medinet) against pneumoniae relevant H. influenzae antibacterials P. aeruginosa PHAC (Public Health Agency of Canada)
TRUST130, 213, 245 United States (~434 healthcare institutions; centralised AMR surveillance funded Hospitals Susceptibility data for respiratory tract infections; resistance trends over time and geographic region S. pneumoniae H. influenzae M. catarrhalis publications AWARE surveillance program246 United States (9 US census regions; 71 medical centres) AMR resistance funded Organism Hospitals Susceptibility testing of respiratory or bloodstream isolates against ceftaroline and comparators S. pneumoniae H. influenzae M. catarrhalis publications ARMOR247 United States (34 institutions) Surveillance study funded (Bausch & Lomb, Eurofins Medinet) Infection/ organism Healthcare institutions Susceptibility profile of isolates from ocular infections against relevant antibacterials S. aureus staphylococci, S. pneumoniae H. influenzae P. aeruginosa publications PHAC (Public Health Agency of Canada)
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx